Evidence map›Paper›PMID 20718957›Full record

ArticleBMC infectious diseases2010

In vivo expression of innate immunity markers in patients with Mycobacterium tuberculosis infection.

Pantelis Constantoulakis, Eftihia Filiou, Nikoletta Rovina, George Chras, Aggeliki Hamhougia, Simona Karabela, Adamandia Sotiriou, Charis Roussos, Nikolaos Poulakis

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Tuberculosis-resistant transgenic cattle.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Expression of toll-like receptor 2 and plasma level of interleukin-10 are associated with outcome in tuberculosis.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2012
    Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Pantelis ConstantoulakisLocus Medicus, Molecular Pathology and Genetics Dept., Athens, Greece.
Eftihia Filiou
Nikoletta Rovina
George Chras
Aggeliki Hamhougia
Simona Karabela
Adamandia Sotiriou
Charis Roussos
Nikolaos Poulakis
Sotiria General Hospital · GRNational and Kapodistrian University of Athens · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundToll-like receptors (TLRs), Coronin-1 and Sp110 are essential factors for the containment of Mycobacterium tuberculosis infection. The purpose of this study was to investigate the in vivo expression of these molecules at different stages of the infection and uncover possible relationships between these markers and the state of the disease.

methodsTwenty-two patients with active tuberculosis, 15 close contacts of subjects with latent disease, 17 close contacts of subjects negative for mycobacterium antigens and 10 healthy, unrelated to patients, subjects were studied. Quantitative mRNA expression of Coronin-1, Sp110, TLRs-1,-2,-4 and -6 was analysed in total blood cells vs an endogenous house-keeping gene.

resultsThe mRNA expression of Coronin-1, Sp110 and TLR-2 was significantly higher in patients with active tuberculosis and subjects with latent disease compared to the uninfected ones. Positive linear correlation for the expression of those factors was only found in the infected populations.

conclusionsOur results suggest that the up-regulation of Coronin-1 and Sp110, through a pathway that also includes TLR-2 up-regulation may be involved in the process of tuberculous infection in humans. However, further studies are needed, in order to elucidate whether the selective upregulation of these factors in the infected patients could serve as a specific molecular marker of tuberculosis.

Indexed as

Gene Expression ProfilingImmunity, Innate4-ButyrolactoneAcetogeninsAdultBloodCells, CulturedFemaleHumansMaleMiddle AgedMinor Histocompatibility AntigensMycobacterium tuberculosisNuclear ProteinsRNA, MessengerToll-Like Receptors4-ButyrolactoneAcetogeninscoronin acetogeninMinor Histocompatibility AntigensNuclear ProteinsRNA, MessengerSp110 protein, humanToll-Like Receptors

Identifiers

PMID20718957
PMCPMC2931512
OpenAlexW2094231987

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.